Portal de Periódicos da CAPES

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022

2022; Karger Publishers; Volume: 17; Issue: 4 Linguagem: Inglês

10.1159/000524879

1661-3805

Nina Ditsch, Achim Wöcke, Michael Untch, Christian Jackisch, Ute‐Susann Albert, Maggie Banys‐Paluchowski, Ingo Bauerfeind, Jens‐Uwe Blohmer, Wilfried Budach, Peter Dall, Eva Maria Fallenberg, Peter A. Fasching, Tanja Fehm, Michael Friedrich, Bernd Gerber, Oleg Gluz, Nadia Harbeck, Jörg Heil, Jens Huober, Hans Kreipe, David Krug, Thorsten Kühn, Sherko Kümmel, Cornelia Kolberg‐Liedtke, Sibylle Loibl, Diana Lüftner, Michael P. Lux, Nicolaì Maass, Christoph Mundhenke, Ulrike Nitz, Tjoung‐Won Park‐Simon, Toralf Reimer, Kerstin Rhiem, Achim Rody, Marcus Schmidt, Andreas Schneeweiß, Florian Schütz, Hans‐Peter Sinn, Christine Solbach, Erich‐Franz Solomayer, Elmar Stickeler, Christoph Thomssen, Isabell Witzel, Volkmar Müller, Wolfgang Janni, Marc Thill,

Metastasis and carcinoma case studies

<b><i>Introduction:</i></b> The AGO (Arbeitsgemeinschaft Gynäkologische Onkologie, German Gynecological Oncology Group) Task Force on Diagnosis and Treatment of Breast Cancer as an interdisciplinary team consists of specialists from gynecological oncology, pathology, diagnostic radiology, medical oncology, and radiation oncology with a special focus on breast cancer. <b><i>Methods:</i></b> The updated evidence-based treatment recommendation 2022 for early breast cancer (EBC) and metastatic breast cancer of the AGO Task Force has been released. <b><i>Results and Conclusion:</i></b> This paper captures the update of EBC.